Triazikvon

Triazikvon
(IUPAC) ime
	2,3,5-tris(aziridin-1-il)benzo-1,4-hinon
Klinički podaci
Identifikatori
CAS broj	68-76-8
ATC kod	L01AC02
PubChem	6235
UNII	F3D5D9P25I
KEGG	C19542
Hemijski podaci
Formula	C12H13N3O2
Mol. masa	231,25 g/mol
SMILES	eMolekuli & PubHem
InChI
	InChI=1S/C12H13N3O2/c16-9-7-8(13-1-2-13)12(17)11(15-5-6-15)10(9)14-3-4-14/h7H,1-6H2 ; Key: PXSOHRWMIRDKMP-UHFFFAOYSA-N
Sinonimi	2,3,5-Tris(aziridin-1-yl)cyclohexa-2,5-diene-1,4-dione
Farmakoinformacioni podaci
Trudnoća	?
Pravni status

Triazikvon je lek koji se koristi u hemoterapiji.

On je alkilirajući agens. On može da reaguje sa DNK da formira međulančane veze.^[4]

Reference

↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑ Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.
↑ Begleiter A (November 2000). „Clinical applications of quinone-containing alkylating agents”. Front. Biosci. 5: E153–71. DOI:10.2741/begleit. PMID 11056078.

	Portal Medicina
	Portal Hemija